Coefficient (95% CI) | P value | |
---|---|---|
Piperacillin-tazobactam | − 1.84 (− 3.26 to − 0.42) | 0.017* |
Age (decade) | 0.43 (0.04–0.83) | 0.043* |
Charlson comorbidity index | 0.45 (0.16–0.74) | 0.004* |
SOFA Score | 0.07 (− 0.13–0.27) | 0.51 |
VRE colonization | − 0.073 (− 1.18–1.06) | 0.90 |
Admission diagnosis | ||
Cardiopulmonary disorder | 0.67 (− 5.421–6.707) | 0.84 |
Neurologic abnormality | 2.41 (− 4.534–9.273) | 0.52 |
Trauma | 1.35 (− 5.104–7.798) | 0.70 |
Sepsis syndrome | 1.45 (− 4.582–7.428) | 0.65 |
Non-infectious transplant complication | − 0.53 (− 7.275–6.276) | 0.89 |
Gastrointestinal abnormality | 2.30 (− 3.944–8.433) | 0.49 |
Complications of chemotherapy | 0.40 (− 5.607–6.357) | 0.90 |
REML criteria at convergence: 571.6 |